Therefore, our study provides novel insights into the molecular mechanism regulating Wnt5a/Ca2+ in the pathogenesis of CAVD, targeting ECH1 may prove of therapeutic potential to aortic valve calcification. This evidence concerns the gene WNT5A and congenital bilateral aplasia of vas deferens from CFTR mutation.